SeqCente, an ARCHIMED LIFE SCIENCE TOOLS & DIAGNOSTICS company, is a growing genomics services company providing high-quality next-generation sequencing (NGS), long-read sequencing, and bioinformatics solutions to academic, biotechnology, pharmaceutical, AgBio and other research organizations.
SeqCenter provides advanced DNA and RNA sequencing and bioinformatics services to academic, biotechnology, AgBio, pharmaceutical, and research organizations. Our mission is to make high-quality genomics services accessible through scientific expertise, reliable turnaround times, and exceptional customer support.
We are seeking a detail-oriented, proactive, and customer-focused Customer Service Specialist to support our growing customer base.
The Customer Service Specialist will serve as a primary point of contact for customers throughout their sequencing project journey, from initial inquiries and order submission through project completion and data delivery.
The ideal candidate will combine excellent communication and organizational skills with a basic understanding of molecular biology, genetics, or genomics. This position plays an important role in delivering positive customer experience, and supporting long-term business growth.

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.
Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.